A phase I study of a 24 hour infusion of gemcitabine in previously untreated patients with inoperable non-small-cell lung cancer.

Lignende værker

• Phase II study of gemcitabine and vindesine in patients with previously untreated non-resectable non-small-cell lung cancer
  af: Sørensen, J B, et al.
  Udgivet: (1999)
• A Multicenter Phase I/II Study of Obatoclax Mesylate Administered as a 3- or 24-Hour Infusion in Older Patients with Previously Untreated Acute Myeloid Leukemia
  af: Schimmer, Aaron D., et al.
  Udgivet: (2014)
• Phase II trial of weekly 24-hour infusion of gemcitabine in patients with advanced gallbladder and biliary tract carcinoma
  af: von Delius, Stefan, et al.
  Udgivet: (2005)
• A randomised phase II study of weekly paclitaxel or vinorelbine in combination with cisplatin against inoperable non-small-cell lung cancer previously untreated
  af: Chen, Y-M, et al.
  Udgivet: (2004)
• Phase II study of irinotecan combined with carboplatin in previously untreated small-cell lung cancer
  af: Kinoshita, A, et al.
  Udgivet: (2006)